Davis Polk advised the bookrunners and co-managers in the offering. Hilton Grand Vacations Borrower Escrow LLC and Hilton Grand Vacations Borrower Escrow Inc., both subsidiaries of...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton and Claro & Cia advised CAP SA on the transaction. Davis Polk & Wardwell and Philippi Prietocarrizosa Ferrero DU & Uría...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton and Claro & Cia advised CAP SA on the transaction. Davis Polk & Wardwell and Philippi Prietocarrizosa Ferrero DU & Uría...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the several underwriters in the offering. Aveanna Healthcare Holdings Inc. executes its $458.8 million initial public offering of 38,236,000 shares of common stock. Aveanna’s common...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters. Vaccitech (Nasdaq: VACC) announced its initial public offering...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. GYP Holdings III Corp., a subsidiary of GMS, Inc., executed its offering of $350 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. The $2 billion in aggregate principal amount of senior notes issued by Marvell Technology, Inc., a wholly owned...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the underwriters in the offering. Boston Omaha Corporationexecuted its $66.1 million offering of 2,645,000 shares of Class A common stock, which includes...
You must be a Standard 1 Year member to access this content.
